Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 12 Apr 2024
In more recent birth cohorts, the strength of the association grew.
Read Full NewsAD109 Yields Numerically Greater OSA Improvements in Postmenopausal Women
CHEST 2026: Day 3 Recap — 6 Headlines to Know
Downar outlines the randomized trial needed to confirm optimal TMS dosing and addresses a safety ceiling on total pulses.
The chief research and medical affairs officer at the National MS Society discussed AI-enabled imaging, biomarkers of progression, women's health across the lifespan, and the Society's Campaign to End MS.
One-year data from the phase 3 AQUARELLE study found that divozilimab, an anti-CD20 antibody, reduced relapse risk in patients with neuromyelitis optica spectrum disorder.
Early phase 1 data in 3 patients suggest CTA313, an allogeneic CD19/BCMA CAR-T, may stabilize disability with a manageable safety profile in progressive MS.
Fast Track status covers AV-1959R, an investigational amyloid-beta vaccine, for preventing Alzheimer disease in cognitively unimpaired adults with amyloid pathology.
1.
A better option for mild to moderate depression?
2.
Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death
3.
CAR-T Warning for Secondary Malignancies: Warranted or Not?
4.
Chemo causes lasting physical decline in breast cancer survivors
5.
investigating radiation oncology applications of artificial general intelligence.
1.
The Importance of Early Detection in Angiosarcoma: A Story of Survival
2.
Precision Erythropoietic Modeling for Hematologic Disorders
3.
Practical Breakthroughs in Oncology Across Clinical Settings
4.
Understanding the HAS-BLED Score: What It Is and Why It Matters
5.
Next-Generation Bone Marrow Harvest Technologies
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
2.
Blood Clotting Disorders Explained
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
4.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
5.
Case-Based Learning: Oncology
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge